Henrietta Lacks' estate sues biotech company over use of her 'immortal' cells

A Massachusetts-based life sciences giant has found itself at the center of a battle over profits from "HeLa" cells, a cell line unethically taken from a Black woman named Henrietta Lacks who was being treated at Johns Hopkins in Baltimore in the 1950s. Thermo Fisher Scientific Inc. (NYSE: TMO) is facing a lawsuit from the Lacks estate. The suit asks the court to order the biotech to “disgorge the full amount of its net profits obtained by commercializing the HeLa cell line to the Estate of Henrietta…
Source: bizjournals.com Health Care:Physician Practices headlines - Category: American Health Authors: Source Type: news